Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of Standard of Care Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma

Blood blood.2024025945.

https://doi.org/10.1182/blood.2024025945

Published: 2024

Includes: Supplemental data

Journal Articles

Paroxysmal nocturnal hemoglobinuria–related thrombosis in the era of novel therapies: a 2043-patient-year analysis

Carmelo Gurnari, Hussein Awada, Simona Pagliuca, Danai Dima, Fauzia Ullah, Naomi Kawashima, Yasuo Kubota, Ceylan Colak, Valeria Visconte, Bhumika J. Patel, Vikram Dhillon, Naimisha Marneni, Suresh Kumar Balasubramanian, Ashwin Kishtagari, Taha Bat, Jaroslaw P. Maciejewski

Blood (2024) 144 (2): 145–155.

https://doi.org/10.1182/blood.2024023988

Published: 2024

Journal Articles

LGL in MGUS or MGUS in LGL? Lessons of Nature and Their Clinical Implications

Carlos Bravo-Perez, Carmelo Gurnari, Naomi Kawashima, Danai Dima, Olisaemeka Ogbue, Luca Guarnera, Yasuo Kubota, Nakisha D Williams, Arooj Ahmed, Fauzia Ullah, Arda Durmaz, Megan Nakashima, Valeria Visconte, Jaroslaw P. Maciejewski

Blood (2023) 142 (Supplement 1): 4769.

https://doi.org/10.1182/blood-2023-181975

Published: 2023

Journal Articles

Efficacy and Safety of Idecabtagene Vicleucel (ide-cel) in Patients with Relapsed-Refractory Multiple Myeloma (RRMM) Not Meeting the Karmma Trial Eligibility Criteria: A Real-World Multicenter Study

Danai Dima, Aliya Rashid, James A Davis, Hussein Awada, Al-Ola Abdallah, Hong Li, Shaun DeJarnette, Leyla Shune, Jack Khouri, Hamza Hashmi, Joseph P McGuirk, Faiz Anwer, Nausheen Ahmed

Blood (2023) 142 (Supplement 1): 4885.

https://doi.org/10.1182/blood-2023-180368

Published: 2023

Journal Articles

Outcomes of BCMA-Directed Chimeric Antigen Receptor T-Cell (CART) Therapy in Patients with Relapse-Refractory Multiple Myeloma with Extramedullary Disease

Danai Dima, James A Davis, Aliya Rashid, Mikhaila Rice, Shaun DeJarnette, Leyla Shune, Jack Khouri, Shahzad Raza, Joseph P McGuirk, Faiz Anwer, Nausheen Ahmed, Al-Ola Abdallah, Hamza Hashmi

Blood (2023) 142 (Supplement 1): 4882.

https://doi.org/10.1182/blood-2023-181331

Published: 2023

Journal Articles

Neighborhood Socioeconomic Disadvantage and Distance from Treatment Center Do Not Impact Survival Outcomes of Patients with Non-Hodgkin Lymphoma and Multiple Myeloma Treated with CAR T-Cell Therapies

Agrima Mian, Danai Dima, Betty K. Hamilton, Allison Winter, Jack Khouri, Louis S. Williams, Shahzad Raza, Deepa Jagadeesh, Aaron T. Gerds, Robert M. Dean, Matt Kalaycio, Claudio Brunstein, Craig S Sauter, Faiz Anwer, Brian T. Hill, Paolo Caimi

Blood (2023) 142 (Supplement 1): 7399.

https://doi.org/10.1182/blood-2023-188712

Published: 2023

Journal Articles

Outcomes of Antithymocyte Globulin and Cyclosporine for Severe Aplastic Anemia

Fauzia Ullah, Danai Dima, Carmelo Gurnari, Arooj Ahmed, Olisaemeka Ogbue, Mark Orland, Naomi Kawashima, Carlos Bravo-Perez, Serhan Unlu, Luca Guarnera, Najiullah Omar, Valeria Visconte, Jaroslaw P. Maciejewski

Blood (2023) 142 (Supplement 1): 5648.

https://doi.org/10.1182/blood-2023-191264

Published: 2023

Journal Articles

Molecular Expression Differences in Blood Mononuclear Cells in Patients with AL Amyloidosis

David Kaplan, Eric Christian, Jason Valent, Faiz Anwer, Shahzad Raza, Sandra Mazzoni, Christy J. Samaras, Louis S. Williams, Danai Dima, Kelly Shepherd, Jared Fennema, Sherry Fada, Megan Nakashima, Mazen Hanna, Hillard M. Lazarus, Jack Khouri

Blood (2023) 142 (Supplement 1): 5031.

https://doi.org/10.1182/blood-2023-180735

Published: 2023

Journal Articles

Insights into Large Granular Lymphocytic Leukemia-Associated Hemolytic Anemia: Clinical Associations, Therapeutic Responses, and Optimal Management Strategies from a Large Institutional Study

Olisaemeka Ogbue, Serhan Unlu, Danai Dima, Carlos Bravo-Perez, Nakisha D Williams, Arooj Ahmed, Sindhusha Veeraballi, Arda Durmaz, Fauzia Ullah, Carmelo Gurnari, Valeria Visconte, Jaroslaw P. Maciejewski

Blood (2023) 142 (Supplement 1): 5167.

https://doi.org/10.1182/blood-2023-186071

Published: 2023

Journal Articles

Alternative Lymphodepletion Strategies Lead to Similar Response Rates and Toxicities in Standard-of-Care BCMA-Directed CAR-T Therapy in Relapsed Refractory Multiple Myeloma

Blood (2023) 142 (Supplement 1): 3499.

https://doi.org/10.1182/blood-2023-187565

Published: 2023

Journal Articles

Impact of Frailty on Outcomes after CAR T-Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma

James A Davis, Danai Dima, Nausheen Ahmed, Shaun DeJarnette, Joseph P McGuirk, Jack Khouri, Jason Valent, Faiz Anwer, Al-Ola Abdallah, Hamza Hashmi

Blood (2023) 142 (Supplement 1): 3503.

https://doi.org/10.1182/blood-2023-179981

Published: 2023

Journal Articles

Del(20q) As a Somatic Gene Rescue in Adult Patients: Can Germline Mutations Other Than SBDS be Found in Affected Patients?

Mark Orland, Yasuo Kubota, Danai Dima, Carlos Bravo-Perez, Luca Guarnera, Carmelo Gurnari, Jaroslaw P. Maciejewski, Valeria Visconte

Blood (2023) 142 (Supplement 1): 4095.

https://doi.org/10.1182/blood-2023-191101

Published: 2023

Journal Articles

Outcomes of Venetoclax-Based Therapy in Patients with Daratumumab-Refractory t(11;14) Positive Light Chain Amyloidosis

Mark Orland, Danai Dima, Fauzia Ullah, Hussein Awada, Diana Basali, Beth M. Faiman, Cynthia Scott, Sandra Mazzoni, Louis S. Williams, Christy J. Samaras, Jason Valent, Faiz Anwer, Shahzad Raza, Jack Khouri

Blood (2023) 142 (Supplement 1): 2031.

https://doi.org/10.1182/blood-2023-183030

Published: 2023

Journal Articles

Lessons of Nature in Trisomy-8 MDS and AML: Determinants of Clonal Drive

Hussein Awada, Yasuo Kubota, Carmelo Gurnari, Carlos Bravo-Perez, Serhan Unlu, Luca Guarnera, Danai Dima, Arda Durmaz, Hassan Awada, Jaroslaw P. Maciejewski, Valeria Visconte

Blood (2023) 142 (Supplement 1): 5707.

https://doi.org/10.1182/blood-2023-190773

Published: 2023

Journal Articles

Trends in Access to Cellular Therapies in Multiple Myeloma (TACTUM): Perspectives of Treating Versus Referring Physicians

Rawan Atallah, Md Saiful Islam Saif, Danai Dima, Anuj Shrestha, Faiz Anwer, Muhammad Umair Mushtaq, Forat Lutfi, Leyla Shune, Hamza Hashmi, Siddhartha Ganguly, Joseph P McGuirk, Shebli Atrash, Al-Ola Abdallah, Rahul Banerjee, Nausheen Ahmed

Blood (2023) 142 (Supplement 1): 6678.

https://doi.org/10.1182/blood-2023-181218

Published: 2023

Journal Articles

Insights into Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: A 12-Year Experience of a Large Academic Center

Danai Dima, Fauzia Ullah, Serhan Unlu, Diana Basali, Mahir Khan, Abdullah Saeed Khan, Xuefei Jia, Majid Jaberi-Douraki, Beth M. Faiman, Sandra Mazzoni, Louis S. Williams, Christy J. Samaras, Jason Valent, Faiz Anwer, Jack Khouri, Shahzad Raza

Blood (2023) 142 (Supplement 1): 3407.

https://doi.org/10.1182/blood-2023-181365

Published: 2023

Journal Articles

Reverse Engineering of Antigenic Peptides in LGL to Decipher Disease Triggers

Arda Durmaz, Carmelo Gurnari, Simona Pagliuca, Colin Hercus, Carlos Bravo-Perez, Luca Guarnera, Nakisha D Williams, Danai Dima, Ishani Nautiyal, Yasuo Kubota, Naomi Kawashima, Jacob Scott, Valeria Visconte, Jaroslaw P. Maciejewski

Blood (2023) 142 (Supplement 1): 246.

https://doi.org/10.1182/blood-2023-190381

Published: 2023

Journal Articles

Outcomes of Salvage VDT-PACE-like Regimens in Relapsed-Refractory Multiple Myeloma: 10-Year Experience of a Large Academic Institution

Arooj Ahmed, Danai Dima, Kerri Row, Fauzia Ullah, Hussein Awada, Diana Basali, Heena Kurish, Mikhaila Rice, Joslyn Rudoni, Marissa Duco, Beth M. Faiman, Jack Khouri, Sandra Mazzoni, Louis S. Williams, Shahzad Raza, Christy J. Samaras, Jason Valent, Faiz Anwer

Blood (2023) 142 (Supplement 1): 4724.

https://doi.org/10.1182/blood-2023-182972

Published: 2023

Journal Articles

Pooled Analysis on Bispecific Antibody-Related Toxicities in Multiple Myeloma

Mobina Golmohammadi, Danai Dima, Maram Albayyadhi, Azam Moradi, Shahzad Raza, Majid Jaberi-Douraki

Blood (2023) 142 (Supplement 1): 1953.

https://doi.org/10.1182/blood-2023-191305

Published: 2023

Journal Articles

An Ensemble Machine Learning Model Using Gradient Boosting Identifies Patients with Disease Progression in Newly Diagnosed Multiple Myeloma

Louis S. Williams, Bardia Khosravi, Marko Velimirovic, Jack Khouri, Shahzad Raza, Sandra Mazzoni, Christy J. Samaras, Hussein Awada, Danai Dima, Jason Valent, Faiz Anwer

Blood (2023) 142 (Supplement 1): 1990.

https://doi.org/10.1182/blood-2023-188762

Published: 2023

NARROW

Safety and Efficacy of Standard of Care Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma

Paroxysmal nocturnal hemoglobinuria–related thrombosis in the era of novel therapies: a 2043-patient-year analysis

LGL in MGUS or MGUS in LGL? Lessons of Nature and Their Clinical Implications

Efficacy and Safety of Idecabtagene Vicleucel (ide-cel) in Patients with Relapsed-Refractory Multiple Myeloma (RRMM) Not Meeting the Karmma Trial Eligibility Criteria: A Real-World Multicenter Study

Outcomes of BCMA-Directed Chimeric Antigen Receptor T-Cell (CART) Therapy in Patients with Relapse-Refractory Multiple Myeloma with Extramedullary Disease

Neighborhood Socioeconomic Disadvantage and Distance from Treatment Center Do Not Impact Survival Outcomes of Patients with Non-Hodgkin Lymphoma and Multiple Myeloma Treated with CAR T-Cell Therapies

Outcomes of Antithymocyte Globulin and Cyclosporine for Severe Aplastic Anemia

Molecular Expression Differences in Blood Mononuclear Cells in Patients with AL Amyloidosis

Insights into Large Granular Lymphocytic Leukemia-Associated Hemolytic Anemia: Clinical Associations, Therapeutic Responses, and Optimal Management Strategies from a Large Institutional Study

Alternative Lymphodepletion Strategies Lead to Similar Response Rates and Toxicities in Standard-of-Care BCMA-Directed CAR-T Therapy in Relapsed Refractory Multiple Myeloma

Impact of Frailty on Outcomes after CAR T-Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma

Del(20q) As a Somatic Gene Rescue in Adult Patients: Can Germline Mutations Other Than SBDS be Found in Affected Patients?

Outcomes of Venetoclax-Based Therapy in Patients with Daratumumab-Refractory t(11;14) Positive Light Chain Amyloidosis

Lessons of Nature in Trisomy-8 MDS and AML: Determinants of Clonal Drive

Trends in Access to Cellular Therapies in Multiple Myeloma (TACTUM): Perspectives of Treating Versus Referring Physicians

Insights into Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: A 12-Year Experience of a Large Academic Center

Reverse Engineering of Antigenic Peptides in LGL to Decipher Disease Triggers

Outcomes of Salvage VDT-PACE-like Regimens in Relapsed-Refractory Multiple Myeloma: 10-Year Experience of a Large Academic Institution

Pooled Analysis on Bispecific Antibody-Related Toxicities in Multiple Myeloma

An Ensemble Machine Learning Model Using Gradient Boosting Identifies Patients with Disease Progression in Newly Diagnosed Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only